NCT01327911View on ClinicalTrials.gov

Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Idiopathic Juxtafoveal Telangiectasia
Interventions
BIOLOGICAL

NT-501 implant

Ciliary neurotrophic factor (CNTF) implant

Trial Locations (2)

44122

Retina Associates of Cleveland, Cleveland

90095

Jules Stein Eye Institute, Los Angeles

Sponsors
All Listed Sponsors
collaborator

The Lowy Medical Research Institute Limited

OTHER

lead

Neurotech Pharmaceuticals

INDUSTRY

NCT01327911 - Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel) | Biotech Hunter | Biotech Hunter